Aleafia Health Inc.
ALEAF · OTC
3/31/2023 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.00 | -0.00 | 0.00 |
| FCF Yield | -982,804.12% | -6,830,449.16% | -16,775,425.55% | -14,035,861.61% |
| EV / EBITDA | -4.18 | 0.18 | -0.63 | 1.45 |
| Quality | ||||
| ROIC | -57.31% | 70.12% | -5.86% | -19.91% |
| Gross Margin | 14.00% | -12.59% | 127.10% | 83.73% |
| Cash Conversion Ratio | 0.10 | 0.03 | 0.78 | 0.56 |
| Growth | ||||
| Revenue 3-Year CAGR | 37.87% | 137.38% | 912.22% | – |
| Free Cash Flow Growth | 0.00% | 45.87% | -109.14% | -1,590.06% |
| Safety | ||||
| Net Debt / EBITDA | -4.18 | 0.18 | -0.63 | 1.45 |
| Interest Coverage | -1.87 | 0.38 | -3.76 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 1.94 | 1.69 | -0.13 | 0.92 |
| Cash Conversion Cycle | 144.57 | 213.82 | -978.65 | -1,591.33 |